The Variability of HR+ Breast Cancer
Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016
Sunil Verma, MD, MSEd, FRCPC discusses treatment options for this type of cancer.
Dr. Sanjiv Agarwala analyzes anti-PD-1 and anti-PD-L1 therapies in terms what they do and their unique toxicities and response patterns.
Dr Argawala discusses how the cost, access and quality of oncology care will be defined with new personalized medicine strategies and therapies.